Amber Tong

China’s Brain-Chip Startups Race Toward Commercial Medical Use

Bloomberg Primer reports on the race to commercialize brain-computer interfaces through NeuroXess, a Shanghai startup testing an implanted device in a paralyzed patient. The source presents BCI less as near-term human enhancement than as an assistive medical technology still facing safety, regulatory and reimbursement tests, while arguing that China’s policy support could help its companies compete with better-funded US rivals.